ESAB · ESAB Corp

Track ESAB — free

$66.85 +1.97 (+3.04%) At close · Oct 9

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$4.16B

62.17M

Volume · Oct 9 1.09M Avg daily vol (3M) 845.38K

Up next

Next earnings call

Nov 7, 2026 Est · unconfirmed · in 4 wks

Latest filing: 10-Q

filed Aug 6, 2026

Q2 2026 earnings call transcript

call held Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$3.00B

Trailing 12 months

Net income (TTM)

$170.05M

Trailing 12 months

Revenue growth YoY

+12.9%

Year over year

Operating margin

12.1%

Trailing 12 months

P / E (TTM)

24.2

Trailing earnings · reciprocal yield 4.1%

FCF yield

4.7%

TTM · current market cap

Return on invested capital

6.1%

Trailing 12 months

Net cash

−$2.18B

Latest balance sheet

Dividend yield

0.7%

Trailing 12 months

Shares change YoY

+0.5%

Year over year · more shares

Price change (1Y)

-43.6%

Trailing year

Short interest

8.3%

Latest settlement · 4.8 days to cover

View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 6, 2026

Q2 FY26

TL;DR. ESAB delivered record second-quarter sales, a return to organic growth in both segments, 8% adjusted EBITDA growth, and closed the Eddyfi acquisition ahead of schedule. It raised 2026 core sales and adjusted EBITDA guidance following the acquisition, while cutting adjusted EPS guidance and flagging margin pressure from price-cost neutrality, logistics costs, commodity inflation, and growth investments.

Bullish

+ Second-quarter total sales rose 12.9% to a record, while core organic sales increased 2.5%.

Bearish

− Core adjusted EBITDA margin declined 90 basis points year over year to 19.5% because of price-cost neutrality and targeted commercial investments.
− Adjusted EPS guidance was reduced to $5.40-$5.50 from $5.70-$5.90.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice

Overall

Strong Sell

SellHoldBuy

Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High

Market backdrop VIX 14.8 · calm Equity put/call 0.56

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −31%

below

Price vs 50-day avg −12%

below

RSI (14) 43

neutral

MACD trend Positive

52-week position 3%

near low

Momentum

relative strength

Very Weak

1-month return −5%

trailing

6-month return −38%

trailing

YTD return −40%

this year

Relative strength −48%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $76 › 200d $97 — 200d above 50d

Institutional flow Accumulating

14 of 348 funds reported for Sep 30 · net +108.9K sh shares · +2 new

Insider flow Distributing

Net -$95.0K over 90 days · 100% sells

Short interest Rising

8.29% of float · ▲ +9.0% MoM · 4.8 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

348 holders — mid 3-yr range

Squeeze score 63

elevated · 0–100

Fundamentals

Weak

Revenue growth +4%

Y/Y

Gross margin 37%

contracting

EPS growth −15%

Y/Y

Free cash flow $213.3M

Valuation P/E 21.3

in line

Balance sheet $1.0B

net debt

Quant / Vol

risk profile

Very High

Volatility 46%

annualized · 1-yr

Max drawdown −52%

past year

ATR 5.1%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Aug 6, 2026

2026 Core net sales growth range · 2026 Non-GAAP 11% – 14%

Acquisitions · 2026 Non-GAAP 9%

Currency · 2026 Non-GAAP 0% – 1%

Guided vs delivered · last 1 settled

Sales full year 2022

guided $2.45B – $2.5B

guided $2.45B – $2.5B $2.59B Beat +4.8%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

3 · 2 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−31% Bearish

Price vs 50-day avg

−12% Bearish

RSI (14)

43 Neutral

MACD trend

Positive Bullish

52-week position

3% Bearish

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $76 › 200d $97 — 200d above 50d

Institutional flow Accumulating

14 of 348 funds reported for Sep 30 · net +108.9K sh shares · +2 new

Insider flow Distributing

Net -$95.0K over 90 days · 100% sells

Short interest Rising

8.29% of float · ▲ +9.0% MoM · 4.8 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

348 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $65 Now $67 · 3% Range high $135

vs 200-day avg -31% vs 50-day avg -12%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EBITDA (Americas) non-GAAP	$64.04M	Three Months Ended July 3, 2026 filing	—
Adjusted EBITDA (EMEA & APAC) non-GAAP	$87.34M	Three Months Ended July 3, 2026 filing	—
Adjusted EBITDA (non-GAAP) non-GAAP	$287.9M	Six Months Ended July 3, 2026	+3.8%

Adjusted EBITDA (non-GAAP) - Total non-GAAP	$151.4M	Three Months Ended July 3, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP Net income from continuing operations $36.4M +$11.7M Income tax expense +$30.6M Interest expense and other, net +$18.3M Restructuring and other related charges +$41.3M Acquisition-amortization and other related charges +$12.3M Depreciation and other amortization +$0.7M Performance option awards compensation expense = Adjusted EBITDA (non-GAAP) - Total $151.4M
Adjusted EBITDA attributable to Russia (non-GAAP) non-GAAP	$2.5M	Six Months Ended July 3, 2026	—
Adjusted EBITDA margin (non-GAAP) non-GAAP	18.7%	Three Months Ended July 3, 2026 filing	—
Adjusted free cash flow (non-GAAP) non-GAAP	$80.9M	Six Months Ended July 3, 2026	—
Adjusted net income from continuing operations (non-GAAP) non-GAAP	$163.1M	Six Months Ended July 3, 2026	—
Adjusted net income margin from continuing operations non-GAAP	10.5%	Six Months Ended July 3, 2026	—
Adjusted net income per share – diluted from continuing operations (non-GAAP) non-GAAP	$2.64	Six Months Ended July 3, 2026	—
Core adjusted EBITDA non-GAAP	$150M	second quarter 2026	—
GAAP → non-GAAP reconciliation GAAP Adjusted EBITDA (non-GAAP) $151.4M -$1.8M Adjusted EBITDA attributable to Russia (non-GAAP) = Core adjusted EBITDA $149.6M
Core adjusted EBITDA (non-GAAP) non-GAAP	$285.5M	Six Months Ended July 3, 2026	+7.2%

Core adjusted EBITDA (non-GAAP) - Americas non-GAAP	$64M	Three Months Ended July 3, 2026 filing	—
Core adjusted EBITDA (non-GAAP) - EMEA & APAC non-GAAP	$85.5M	Three Months Ended July 3, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP Adjusted EBITDA (non-GAAP) - EMEA & APAC $87.3M -$1.8M Adjusted EBITDA attributable to Russia = Core adjusted EBITDA (non-GAAP) - EMEA & APAC $85.5M
Core adjusted EBITDA (non-GAAP) - Total non-GAAP	$149.6M	Three Months Ended July 3, 2026 filing	—
GAAP → non-GAAP reconciliation GAAP Adjusted EBITDA (non-GAAP) - Total $151.4M -$1.8M Adjusted EBITDA attributable to Russia = Core adjusted EBITDA (non-GAAP) - Total $149.6M
Core adjusted EBITDA margin (non-GAAP) non-GAAP	19.3%	Six Months Ended July 3, 2026	—
Core adjusted EBITDA margin (non-GAAP) - Americas non-GAAP	20.3%	Three Months Ended July 3, 2026 filing	—
Core adjusted EBITDA margin (non-GAAP) - EMEA & APAC non-GAAP	19%	Three Months Ended July 3, 2026 filing	—
Core adjusted EBITDA margin (non-GAAP) - Total non-GAAP	19.5%	Three Months Ended July 3, 2026 filing	—
Core adjusted net income from continuing operations (non-GAAP) non-GAAP	$163.2M	Six Months Ended July 3, 2026	—
Core adjusted net income per share – diluted from continuing operations (non-GAAP) non-GAAP	$2.64	Six Months Ended July 3, 2026	—
core organic sales growth non-GAAP	2.5%	second quarter 2026	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Metal Fabrication — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
ESAB ESAB Corp this stock	$4.16B	-40.2%	+3.7%	21.3	8.3%
ATI Ati Inc	$26.12B	+67.2%	-13.4%	56.1	3.5%
CRS Carpenter Technology Corp	$19.12B	+22.5%	+20.0%	36.7	2.9%
MLI Mueller Industries Inc	$13.43B	—	+10.9%	15.8	2.2%
CMC COMMERCIAL METALS Co	$7.07B	-7.7%	+25.6%	12.1	5.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

348

% held: 106.8%
Reported: 14 of 348
Top holder: PRICE T ROWE ASSOCIATES I…

Held Float

View

Held by Funds

Fund positions

415

View

Short & Settlement

Short Interest Rising

Shares short

5.2M

Days to cover: 4.8d
Change: +426.5K sh

View

Short Volume

Short vol %

57%

As of: Oct 9, 2026

Short Total

View

Fails to Deliver

FTD shares

100

Value: $6.9K
As of: Sep 11, 2026

View

Off-Exchange

Off-exchange %

41.6%

Week of: Sep 7, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$95.0K

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Congressional Trades Buy

Member

Thomas H. Kean

Amount: $1.0K–$15.0K
Traded: Jul 7, 2026

View

Financials

Revenue (FY)

$2.8B

Net income (FY): $226.8M
EPS diluted: $3.67

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 6, 2026
This year: 15

View

Proposed Sales

Value

$95.0K

Shares: 1.0K
Filed: Aug 7, 2026

View

Earnings & Events

Webcasts

Last webcast

Aug 6, 2026

View

Performance

	5D	20D	120D	MTD	YTD
ESAB	-4.4%	-5.4%	-37.9%	+1.5%	-40.2%
SPY	+1.2%	+1.9%	+9.9%	+2.1%	+14.2%
vs SPY	-5.5%	-7.3%	-47.8%	-0.6%	-54.3%

Capital returns

Latest dividend

$0.12 / share · ex Oct 2, 2026

Raised 20%

Paid (TTM)

$0.44 / share · 4 payouts

Dividend yield (TTM, derived)

0.66%

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1877322 CUSIP 29605J106 13F (30d) 15 filings 15 filers Visit website Investor relations

ESAB · ESAB Corp

Price & Indicators

Up next

Metrics snapshot

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns